Claraphi Advisory Network’s ResMed RMD Stock Holding History

Claraphi Advisory Network’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-782	Closed	-$206K	–	323
2021 Q3	$206K	Buy	+782	New	+$214K	0.07%	279
2021 Q2	–	Sell	-1,443	Closed	-$280K	–	340
2021 Q1	$280K	Sell	1,443 -791	-35%	-$159K	0.08%	251
2020 Q4	$475K	Buy	2,234 +702	+46%	+$140K	0.13%	145
2020 Q3	$263K	Sell	1,532 -805	-34%	-$149K	0.1%	186
2020 Q2	$449K	Buy	2,337 +1,269	+119%	+$208K	0.19%	112
2020 Q1	$157K	Buy	+1,068	New	+$170K	0.07%	244
2018 Q4	–	Sell	-3,086	Closed	-$356K	–	261
2018 Q3	$356K	Buy	3,086 +220	+8%	+$24.1K	0.2%	129
2018 Q2	$297K	Buy	2,866 +210	+8%	+$21.2K	0.19%	156
2018 Q1	$261K	Buy	+2,656	New	+$251K	0.18%	175

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Claraphi Advisory Network's RMD Position: Q4 2021 in Review

Claraphi Advisory Network sold out of ResMed (RMD) in Q4 2021, closing a stake of 782 shares — an estimated $206K sold.

Claraphi Advisory Network first reported a position in RMD in Q1 2018 and held it in 9 quarters. The position peaked at $475K in Q4 2020. 723 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

Claraphi Advisory Network reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
Claraphi Advisory Network sold 782 ResMed shares in Q4 2021, an estimated $206K.
Claraphi Advisory Network first reported a position in ResMed in Q1 2018 and held it in 9 quarters.
Claraphi Advisory Network's ResMed position peaked at $475K in Q4 2020.
723 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on Claraphi Advisory Network's 13F filing for Q4 2021, filed 7 Feb 2022.